Business Context and Reporting Period
Envoy Medical, Inc. (formerly Anzu Special Acquisition Corp I) filed a Form 8-K Current Report on June 24, 2024. The company is an emerging growth company incorporated in Delaware with principal executive offices in White Bear Lake, MN. Its Class A Common Stock (COCH) and Redeemable Warrants (COCHW) trade on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing is a Current Report regarding a material definitive agreement and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial performance metrics.
Material Changes
The primary material change reported is the execution of Amendment No. 1 to the Common Stock Purchase Warrant on June 24, 2024, between Envoy Medical, Inc. and the Meteora FPA Parties (Meteora Special Opportunity Fund I, LP, Meteora Capital Partners, LP, Meteora Select Trading Opportunities Master, LP, and Meteora Strategic Capital, LLC). This amendment extends the expiration date of 3,874,394 Shortfall Warrants by six months, from June 30, 2024, to December 31, 2024. These warrants allow the purchase of shares at an exercise price of $10.46 per share.
Guidance, Outlook, and Risks
The filing does not provide management commentary, financial guidance, or an outlook for future periods. The document notes that the issuance and resale of the Shortfall Warrant Shares and the warrants themselves are registered pursuant to the Company's Registration Statement on Form S-1 (File No. 333-276590), declared effective on May 2, 2024. No specific risks or contingencies are detailed in this summary text beyond the standard reference to the full text of the amendment.
Investor Verification Checklist
- Verify the full terms of Amendment No. 1 to the Common Stock Purchase Warrant attached as Exhibit 10.1.
- Confirm the current trading price of Class A Common Stock relative to the $10.46 exercise price of the Shortfall Warrants.
- Review the effective Form S-1 (File No. 333-276590) for details on the registration of the Shortfall Warrant Shares.
- Monitor the company's liquidity position given the extension of warrant obligations to December 31, 2024.